IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation - PubMed (original) (raw)
IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation
Danelle Eto et al. PLoS One. 2011.
Abstract
Cytokines are important modulators of lymphocytes, and both interleukin-21 (IL-21) and IL-6 have proposed roles in T follicular helper (Tfh) differentiation, and directly act on B cells. Here we investigated the absence of IL-6 alone, IL-21 alone, or the combined lack of IL-6 and IL-21 on Tfh differentiation and the development of B cell immunity in vivo. C57BL/6 or IL-21(-/-) mice were treated with a neutralizing monoclonal antibody against IL-6 throughout the course of an acute viral infection (lymphocytic choriomeningitis virus, LCMV). The combined absence of IL-6 and IL-21 resulted in reduced Tfh differentiation and reduced Bcl6 protein expression. In addition, we observed that these cytokines had a large impact on antigen-specific B cell responses. IL-6 and IL-21 collaborate in the acute T-dependent antiviral antibody response (90% loss of circulating antiviral IgG in the absence of both cytokines). In contrast, we observed reduced germinal center formation only in the absence of IL-21. Absence of IL-6 had no impact on germinal centers, and combined absence of both IL-21 and IL-6 revealed no synergistic effect on germinal center B cell development. Studying CD4 T cells in vitro, we found that high IL-21 production was not associated with high Bcl6 or CXCR5 expression. TCR stimulation of purified naïve CD4 T cells in the presence of IL-6 also did not result in Tfh differentiation, as determined by Bcl6 or CXCR5 protein expression. Cumulatively, our data indicates that optimal Tfh formation requires IL-21 and IL-6, and that cytokines alone are insufficient to drive Tfh differentiation.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
Figure 1. IL-21 can be produced by Th1, Th2 or Th17 cell in vitro.
(A–D) Magnetic bead purified total CD4 T cells were stimulated with plate-bound αCD3 plus αCD28 without cytokine blocking mAbs (unbiased, U), or in the presence of αIFNγ + αIL-4 (Th0), IL-12 + αIL-4 (Th1), IL-4 + αIFNγ (Th2), or IL-6/TGFβ + αIFNγ & αIL-4 (Th17). Day 7 CD4+B220− gated in vitro cultured cells were stained by ICS after 4 h stimulation in PMA/ionomycin. Representative dot plots of IL-21 and the respective cytokine associated with each subset, (A) IFNγ (Th1), (B) IL-4 (Th2), or (C) IL-17 (Th17). (D) IL-21 was measured by ELISA from day 7 cells that had been washed, and then restimulated overnight in the presence of PMA/ionomycin. IL-21 was normalized to cell number per well. (E) Sorted naïve CD4 T cells (CD4+CD44−NK1.1−CD25−) were cultured under unbiased (U), Th0 or Th1 conditions. ELISA analysis of IL-21 production from day 7 cultured CD4 T cells restimulated overnight with PMA/ionomycin (normalized to cell number per well). “—” = no stim. Data are representative of ≥2 independent experiments.
Figure 2. In vitro stimulation of purified naïve CD4 T cells with IL-6 or IL-21 drives high IL-21 expression.
(A–D) Naïve sorted CD4 T cells (CD4+CD44−NK1.1−CD25−) were stimulated for 3 days on αCD3/αCD28 coated plates in the presence of αIFNγ, αIL-4, and αTGFβ (Th0) ± IL-6 or IL-21. Reagents to block IL-21 (5 µg/ml) or IL-6 (10 µg/ml) signaling were also added at this time where indicated. IL-21R-Fc intracellular staining was used to identify IL-21 producing cells after 4 h of PMA/ionomycin stimulation. (A) Flow cytometry analysis of IL-21 and IFNγ production in day 7 Th0, Th0 + IL-6, and Th0 + IL-6 + αIL6 polarized CD4 T cell cultures. Cells were gated on B220−CD44hi CD4 T cells. *** P<0.0005. (B–D) FACS analysis of IL-21 and IFNγ production in day 3 Th0 + IL-21± αIL-21 or IL-21R-Fc differentiated CD4 T cells. (B) Representative plots (B220−CD44hi CD4 T cells). (C) Quantitation of IL-21 production or (D) IL-21 MFI. ** P<0.003, *** P<0.0003. Data are representative of ≥2 independent experiments for each condition with duplicate samples. MFI, mean fluorescence intensity.
Figure 3. High IL-21 production in CD4 T cell cultures does not instruct Tfh differentiation.
Naïve sorted CD4 T cells were stimulated for 72 h on αCD3 plus αCD28 coated plates in the presence of αIFNγ, αIL-4, and αTGFβ (Th0) ± IL-6 or IL-21. (A) CXCR5 mRNA expression normalized to a housekeeping gene, G6PDH, in naïve (CD4+CD44lo), day 3 in vitro polarized CD4 T cell cultures (Th0 or Th0 + IL-6), or OTII CD4 T cells from day 8 NP-OVA plus alum in vivo immunized mice (CD44hiCXCR5+GL7− Tfh or CD44hiCXCR5+GL7+ GC Tfh). (B) Quantitation of CXCR5 mean fluorescence intensity (MFI) in day 3 cultures (Th0 or Th0 + IL-6) or CD4 splenocytes (naïve, CD44lo; CXCR5+, CD44hi), and histogram. (C) CXCR5 analysis in 72 h Th0 (black) or Th0 + IL-21 (red) cultures. Th0 and Th0 + IL-21 cultures stained with isotype mAb (blue). (D–E) Timecourse of Bcl6 (D) and Blimp-1 (E) mRNA expression normalized to a housekeeping gene, G6PDH, in Th0 or Th0 + IL-6 CD4 T cell cultures. (F) FACS analysis of Bcl6 protein expression in germinal center B cells (GL7+B220+) versus non GC B cells (GL7−B220+) in splenocytes 8 days following LCMV infection. (G) Bcl6 protein expression in day 3 in vitro differentiated CD4 cultures (Th0 or Th0 + IL-6) versus freshly isolated naïve CD4 splenocytes (CD44lo). Left, quantitation of Bcl6 MFI. Right, Bcl6 histogram. (H) Bcl6 analysis in 72 h Th0 (black) or Th0 + IL-21 (red) cultures. Naïve splenocytes are stained for comparison (CD44lo, gray). Data are representative of ≥2 independent experiments with duplicate samples.
Figure 4. Cooperation of IL-6 and IL-21 for plasma cell generation and antibody responses.
C57BL/6 (B6) or IL-21−/− mice treated with αIL-6 or isotype mAb throughout the acute LCMV infection. (A) Titers of anti-LCMV IgG in the serum of B6 or IL-21−/− mice ± αIL-6 mAb 8 days following LCMV infection: B6 vs. B6 + αIL-6 (**, P = 0.0016), B6 vs. IL-21−/− (*, P = 0.025), B6 vs. IL-21−/− + αIL-6 (**, P = 0.0016), and IL-21−/− vs. IL-21−/− + αIL-6 (**, P = 0.0012). (B) Quantitation of plasma cell development by FACS: B6 vs. IL-21−/− (***, P = 0.0008), B6 vs. IL-21−/− + αIL-6 (***, P<0.0001), and IL-21−/− ± anti-IL-6 (*, P = 0.0143). (C) Plasma cell (CD138+IgD−) development 8 days post-infection, gated on CD19+ splenocytes. Data are representative of 3 independent experiments; n = 5–6 mice per group. ns, not significant.
Figure 5. IL-21, but not IL-6, is needed for optimal germinal center B cell development.
(A) Germinal center B cells (GL7+Fas+ gated, total B cell gate shown) in C57BL/6 (B6) or IL-21−/− mice treated with anti-IL-6 (αIL6) or isotype mAb. Splenocytes were analyzed 8 days following acute LCMV infection. (B) Frequency of germinal center B cells of total B cells. *, P<0.02. (C) Quantitation of the PNA mean fluorescence intensity (MFI) in germinal center B cells. ***, P = 0.0003. Data are representative of 3 independent experiments; n = 5–6 mice per group. MFI, mean fluorescence intensity; ns, not significant.
Figure 6. IL-6 or IL-21 is required for optimal Tfh differentiation.
(A–G) Splenocytes were analyzed 8 days following LCMV infection in C57BL/6 (B6) or IL-21−/− mice ± αIL6. (A) Follicular helper T (Tfh) cells (CXCR5+SLAMlo, boxed) gated on activated (CD44hi) CD4 T cells. (B) Percentage of Tfh differentiation (from gated Tfh population). **, P = 0.0016. (C) Quantitation of ΔCXCR5 mean fluorescence intensity (MFI) gated on Tfh (normalized against CD44lo CD4 T cells). **, P = 0.003. ***, P<0.0001. (D) Left, quantitation of Bcl6 protein ΔMFI in Tfh (normalized against CD44lo CD4 T cells). ***, P = 0.0009. Right, histogram overlay shows Bcl6 expression in a representative B6 vs. IL-21−/− + αIL-6 Tfh population (B6, black; IL-21−/− + αIL-6, red; B6 stained with isotype mAb, gray). (E) FACS analysis of germinal center CD4 T (GC Tfh) cells (CXCR5+GL7+, boxed). Gated CD44hi CD4 T cells shown. (F) GC Tfh quantitation. **, P = 0.003. (G) ΔCXCR5 MFI, gated on GC Tfh and normalized against CD44lo CD4 T cells. *, P = 0.0405. Flow cytometric analysis of intracellular cytokine staining for IFNγ production by CD4 T cells after 4 h stimulation with PMA and ionomycin in the presence of brefeldin A. (H) Frequency of IFNγ+CD44hi CD4 T cells. Data are representative of ≥2 independent experiments; n = 5–6 mice per group. MFI, mean fluorescence intensity; ns, not significant.
Similar articles
- CD25(+) Bcl6(low) T follicular helper cells provide help to maturing B cells in germinal centers of human tonsil.
Li H, Pauza CD. Li H, et al. Eur J Immunol. 2015 Jan;45(1):298-308. doi: 10.1002/eji.201444911. Epub 2014 Oct 27. Eur J Immunol. 2015. PMID: 25263533 Free PMC article. - Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall.
Kato Y, Zaid A, Davey GM, Mueller SN, Nutt SL, Zotos D, Tarlinton DM, Shortman K, Lahoud MH, Heath WR, Caminschi I. Kato Y, et al. J Immunol. 2015 Aug 1;195(3):1006-14. doi: 10.4049/jimmunol.1500767. Epub 2015 Jun 22. J Immunol. 2015. PMID: 26101322 - Orphan Nuclear Receptor NR2F6 Suppresses T Follicular Helper Cell Accumulation through Regulation of IL-21.
Olson WJ, Jakic B, Labi V, Schoeler K, Kind M, Klepsch V, Baier G, Hermann-Kleiter N. Olson WJ, et al. Cell Rep. 2019 Sep 10;28(11):2878-2891.e5. doi: 10.1016/j.celrep.2019.08.024. Cell Rep. 2019. PMID: 31509749 Free PMC article. - T follicular helper (Tfh ) cells in normal immune responses and in allergic disorders.
Varricchi G, Harker J, Borriello F, Marone G, Durham SR, Shamji MH. Varricchi G, et al. Allergy. 2016 Aug;71(8):1086-94. doi: 10.1111/all.12878. Epub 2016 May 25. Allergy. 2016. PMID: 26970097 Review. - Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses.
Pedros C, Altman A, Kong KF. Pedros C, et al. Front Immunol. 2018 Oct 22;9:2412. doi: 10.3389/fimmu.2018.02412. eCollection 2018. Front Immunol. 2018. PMID: 30405612 Free PMC article. Review.
Cited by
- Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma.
Lin L, Zou J, Pei S, Huang W, Zhang Y, Zhao Z, Ding Y, Xiao C. Lin L, et al. Heliyon. 2024 Sep 11;10(19):e37726. doi: 10.1016/j.heliyon.2024.e37726. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39391510 Free PMC article. - Differentiation and regulation of CD4+ T cell subsets in Parkinson's disease.
Sun X, Gu R, Bai J. Sun X, et al. Cell Mol Life Sci. 2024 Aug 17;81(1):352. doi: 10.1007/s00018-024-05402-0. Cell Mol Life Sci. 2024. PMID: 39153043 Free PMC article. Review. - Pathway-Based Mendelian Randomization for Pre-Infection IL-6 Levels Highlights Its Role in Coronavirus Disease.
Kamali Z, Esmaeil N, Thio CHL, Vaez A, Snieder H. Kamali Z, et al. Genes (Basel). 2024 Jul 6;15(7):889. doi: 10.3390/genes15070889. Genes (Basel). 2024. PMID: 39062668 Free PMC article. - Transcriptional regulation of Tfh dynamics and the formation of immunological synapses.
Kim YJ, Choi J, Choi YS. Kim YJ, et al. Exp Mol Med. 2024 Jun;56(6):1365-1372. doi: 10.1038/s12276-024-01254-7. Epub 2024 Jun 3. Exp Mol Med. 2024. PMID: 38825646 Free PMC article. Review. - Immunization with a peptide mimicking lipoteichoic acid induces memory B cells in BALB/c mice.
Yi XY, Hou XR, Huang ZX, Zhu P, Liu BY. Yi XY, et al. BMC Infect Dis. 2024 Apr 2;24(1):371. doi: 10.1186/s12879-024-09262-8. BMC Infect Dis. 2024. PMID: 38566017 Free PMC article.
References
- Crotty S, Ahmed R. Immunological memory in humans. Semin Immunol. 2004;16:197–203. - PubMed
- MacLennan IC. Germinal centers. Annu Rev Immunol. 1994;12:117–139. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous